Skip to main content

MEI Pharma, Inc. (NASDAQ: MEIP) Investor Securities Class Action Lawsuit 08/10/2020

  • If you purchased shares of MEI Pharma, Inc. (NASDAQ: MEIP), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 16, 2021 - The case was voluntarily dismissed. August 10, 2020 - An investor in shares of MEI Pharma, Inc. (NASDAQ: MEIP) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by MEI Pharma, Inc. in connection with certain allegedly false and misleading statements made between August 2, 2017, and ...



You must register (for free) or login to view the entire case.